The Outlook for Medical Devices in South East Asia
| Publication Date | March 2008 |
|---|---|
| Publisher | Espicom |
| Product Type | Report |
| Pages | 8 separate reports |
| ISBN Number | not applicable |
| Product Code | ESP00341 |
Summary
11 Key Markets Covered!
Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Switzerland and United Kingdom.
GERMANY
Germany is the third largest medical device market in the world, accounting for 6.4% of the total world market and ranking behind the USA and Japan. In 2006, the German medical device market was estimated at US$11.8 billion, equal to US$143 per capita.
Germany has a history of producing high quality medical equipment. Approximately 85% of domestic production is exported to a wide range of countries. Government funding of hospitals in recent years has remained static, therefore hospitals are maintaining existing equipment rather than investing in new appliances. This has led to domestic producers becoming increasingly reliant on the export market.
FRANCE
France is the world's fourth largest medical device market, behind the USA, Japan and Germany. The continuing deficit of the national health insurance funds, which finance the majority of health expenditure, has prompted a series of reform programmes for the health sector, the latest of which was approved by Parliament in July 2004. New measures have recently been taken to control spending on medical devices, similar to those already in force for pharmaceuticals. For this reason, the medical market is only likely to see moderate growth over the next few years.
Prospects for medical equipment manufacturers remain promising as a result of several initiatives intended to allow France to make good its shortfall in some equipment areas, most notably imaging and radiotherapy equipment, as part of a ten billion euro hospital investment programme. The medical manufacturing industry has seen an influx of foreign companies; most larger manufacturers are now subsidiaries of multinational groups.
ITALY
The provision of healthcare in Italy, in common with other western European countries, is advanced, with universal access. Being initially based on the NHS-model of the UK, the Italian health service is also facing similar scenarios, most notably efforts to restrain rising costs. In an effort to increase efficiency in the healthcare sector, the use of an electronic 'health card' is being tested in Northern Italy. This is similar to the system recently introduced in Austria.
The Ministry of Health has recently embarked on a programme of large-scale investment in the health service. Investment is being linked to certain standards within healthcare provision; in particular is the new focus on preventative care. With the increased levels of investment it is also hoped that there will be parity in provision throughout the regions and that by linking investment to certain standards, disparity will be removed.
UNITED KINGDOM
The UK has one of the largest medical device markets in the world, valued at US$7.6 billion in 2006. The domestic market is the third largest in Europe behind Germany and France. Per capita expenditure is, by comparison, much lower and is similar to that of Belgium.
Increased government funding is guaranteed until 2008; a spending review is planned for 2007 but it is unlikely that the current levels of expenditure will remain, which will allow the private sector to develop further.
The growth of the UK medical device market is predominantly import-led as many domestic manufacturers are not able to rapidly adjust to changes in demand. This led to a trade deficit for the third year in succession in 2004. FOR EVERY MARKET M
SENT QUARTERLY
MARKET OUTLOOK- Current market size
- Unique 5-Year market projections to 2012
- Market outlook
- Market structure
- Statistical data on imports and exports
- Market developments, covering recent and impending developments with respect to key issues such as regulation, health facilities, funding and
- government policy
- Key national data projections
- International market comparisons
FOR EVERY MARKET
BACKGROUND DATA- Population data, including growth trends and age structure
- Demographic indicators detailing principal causes of death and morbidity
- Organisation & administration
- Health expenditure
- Expenditure by source of funding and type
- Hospital services
- Hospital data such as beds by type, region, specialty, patient admissions and surgical procedures
- Outpatient care
- Medical personnel
- Data on healthcare professionals covering such areas as doctors by specialty, nursing staff and dentists
- Regulatory environment
- Distribution guide and trade fair information
- Domestic production
For healthcare organisations and trade associations
Content
- None.
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















